Seeking Alpha

VTUS
  Ventrus Biosciences Inc - NASDAQ

8/21/2014, 8:07 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
VTUS vs. ETF Alternatives
Company Description
Ventrus Biosciences Inc is a development stage specialty pharmaceutical company. The Company is engaged in the late-stage clinical development of gastrointestinal products in areas of unmet need, anal fissures, and fecal incontinence.